Table 3.
3′UTR polymorphic sites | AML patients (n = 19) | HDs (n = 141) |
---|---|---|
Ins/Ins | 0.26 | 0.22 |
Del/Del | 0.37 | 0.30 |
Ins/Del | 0.37 | 0.47 |
InsG/InsG | 0.26 | 0.23 |
DelC/DelC | 0.15 | 0.22 |
InsG/DelC | 0.26 | 0.32 |
DelG/X | 0.32 | 0.23 |
UTR-1 | 0.21 | 0.32 |
UTR-2 | 0.29 | 0.3 |
UTR-3 | 0.16 | 0.09 |
UTR-4 | 0.13 | 0.11 |
UTR-5 | 0.03 | 0.05 |
UTR-6 | 0.05 | 0.02 |
UTR-7 | 0.08 | 0.08 |
UTR-8 | 0.05 | 0.032 |